Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Study of High Dose Intravenous (IV) Ascorbic Acid in Measurable Solid Tumor Disease

This study has suspended participant recruitment.
(Awaiting response from FDA as to status of parenteral ascorbic acid manufactured by Bioniche (Ireland).)
Sponsor:
Information provided by (Responsible Party):
Situs Cancer Research Center
ClinicalTrials.gov Identifier:
NCT01125449
First received: May 16, 2010
Last updated: August 25, 2012
Last verified: August 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has suspended participant recruitment.
  Estimated Study Completion Date: December 2014
  Estimated Primary Completion Date: July 2014 (Final data collection date for primary outcome measure)